Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.3 is added to the Record History, indicating an update to the study record's revision metadata. The previous v3.6.2 entry is removed from the visible history.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows a new Revision: v3.6.2 replacing Revision: v3.6.0. This indicates a newer revision entry has been posted for the study record.SummaryDifference0.1%

- Check35 days agoChange DetectedThe history now indicates the study is no longer looking for participants, clarifying enrollment status. A new record revision v3.6.0 was added and the previous revision v3.5.5 was removed, reflecting an updated version of the study record.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded a new revision entry: v3.5.5. Removed the previous revision entry: v3.5.4.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History. The previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.5.3) was added to the study's history, replacing the previous revision (v3.5.2) and signaling an updated posting date for the record.SummaryDifference0.1%

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.